Clinical Trial Update: Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study [Phase 1]

View source ↗

Summary

A Phase 1 pilot trial aiming to improve insulin resistance to treat non-alcoholic fatty liver disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Northwell Health | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD) | Phase 1 | Status: WITHDRAWN